{"url":"https://lda.senate.gov/api/v1/filings/c3bb2b31-95c5-4a6d-91d2-e5cd49c83efb/","filing_uuid":"c3bb2b31-95c5-4a6d-91d2-e5cd49c83efb","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2013,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c3bb2b31-95c5-4a6d-91d2-e5cd49c83efb/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Andrew Cochran","dt_posted":"2014-01-21T21:30:13.057000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"8509 Paul Revere Ct.","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Annandale","registrant_state":"VA","registrant_zip":"22003","registrant":{"id":400410940,"url":"https://lda.senate.gov/api/v1/registrants/400410940/","house_registrant_id":40594,"name":"ANDREW COCHRAN","description":"Government Relations","address_1":"8509 Paul Revere Ct.","address_2":null,"address_3":null,"address_4":null,"city":"Annandale","state":"VA","state_display":"Virginia","zip":"22003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANDREW COCHRAN","contact_telephone":"+1 703-405-8769","dt_updated":"2022-04-06T16:07:01.783680-04:00"},"client":{"id":190357,"url":"https://lda.senate.gov/api/v1/clients/190357/","client_id":12,"name":"AMERICAN ASSOCIATION FOR JUSTICE","general_description":"Membership organization for plaintiffs' attorneys","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-03-01"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"H.R. 3309 (Innovation Act); to amend title 35, United States Code, and the Leahy-Smith America Invents Act to make improvements and technical corrections.\n\nGeneral lobbying with regard to patent reform proposals, specific interest in proposals that would enact loser pays, mandatory sanctions, limits on discovery, fees on discovery or heightened pleading standards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47276,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"COCHRAN","suffix":null,"suffix_display":null},"covered_position":"Senior Counsel, House Financial Services Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"General lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers.\n\nH.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees.\n\nS.1009 (Chemical Safety Improvement Act of 2013); to improve the safety of consumers and modernize the Toxic Substances Control Act.\n\nGeneral lobbying with regard to the ongoing development of a proposed TAFTA-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47276,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"COCHRAN","suffix":null,"suffix_display":null},"covered_position":"Senior Counsel, House Financial Services Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure.\n\nH.R. 2655/S. 1288 (Lawsuit Abuse Reduction Act of 2013); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47276,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"COCHRAN","suffix":null,"suffix_display":null},"covered_position":"Senior Counsel, House Financial Services Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOR","general_issue_code_display":"Torts","description":"Lobbying with regard to medical malpractice reform proposals generally.\n\nH.R. 3121 (American Health Reform Act); specific interest in provisions establishing national civil liability limitations for medical professionals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47276,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"COCHRAN","suffix":null,"suffix_display":null},"covered_position":"Senior Counsel, House Financial Services Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}